MedPath

Management of Patients With Diagnosis of Hypothyroidism, as Hospitalized and as Outpatients, in Internal Medicine Units: Observational Study Before & After Educational Programme

Completed
Conditions
Hypothyroidism
Interventions
Other: intervening Educational Program
Registration Number
NCT05314790
Lead Sponsor
Fadoi Foundation, Italy
Brief Summary

There is still limited knowledge regarding the clinical profile and appropriateness of treatment in patients with hypothyroidism hospitalized in Internal Medicine (IM) Departments in Italy. The aim of this study is to evaluate: 1) the characteristics of patients and possible deviations from national and international clinical practice recommendations (CPRs) in evidence-based guidelines (EBGs); 2) the improvement of patient management by means of a standardized educational programme (EP).

Methods: A nationwide multicentre study, comprising two replications of a retrospective survey (phases 1 and 3) with an intervening EP (phase 2) in half of the centres and no EP in the other half, was conducted. The EP was based on outreach visits. Centres were assigned to the two arms of the study, labelled the training group (TG) and control group (CG) respectively, by cluster randomization.

Detailed Description

Hypothyroidism (HT) is a common disorder that affects more than 4% of the general population. Since this percentage does increase with advancing age, it is reasonable to suppose that hypothyroidism is becoming a widespread disease condition. Furthermore hypothyroidism is correlated with significant cardiovascular morbidity and mortality.

Although the potential clinical impact of hypothyroidism, the clinical profile of patients affected by hypothyroidism and managed in the Internal Medicine setting it is not very well known so far. This study has the aim to take a real-life picture of Internal Medicine patients with diagnosis of hypothyroidism, in order to evaluate possible deviations between the current clinical practice and the evidence-based guidelines, and possibly improving the management by means of an educational program.

The FADOI-TIAMO study is designed as a replicate of two cross-sectional surveys (Phase 1 and 3) interspersed with an educational program (Phase 2) to be conducted in 11 out of the 22 participating Centres. The data collection in Phases 1 and 3 will be based on the review of medical records of the last 30 consecutive patients with known or de novo diagnosis of HT observed in each Centre (globally, 1200 patients).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1200
Inclusion Criteria
  • known diagnosis of hypothyroidism on the basis of medical history or laboratory results, as indicated in the clinical record of inpatients admitted to the IM department for any condition
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
training group (TG)intervening Educational ProgramGroup who has received an Educational Program (EP). The implementation of an EP based on meetings within the Department, coordinated by an outside tutor (outreach visit model). The EP content was defined beforehand by a Scientific Board, on the basis of evidence-based guidelines (EBGs) and an up-to-date literature review, but also with a specific focus on any departures from standard clinical practice recommendations (CPRs) identified at each IM department in phase 1.
Primary Outcome Measures
NameTimeMethod
Effects of an educational programme4 months for each phase

To evaluate the improvement of some indicators (the same of outcome 1) in the management of patients with hypothyroidism by means of a standardized educational programme (e.g. Number of Patients on LT4 replacement therapy who are not taking oral solution or softgel formulations are on absorption-hindering medication and/or do not comply with timing in relation to meals / Number of patients on LT4 replacement therapy who do not comply with the prescribed timing before meals and/or are taking absorption-hindering medication; Number of patients on replacement therapy with TSH in the ATA target range/ Number of patients on replacement therapy with known TSH; Number of patients on replacement therapy, taking LT4 tablets at least 60' before breakfast or at least 3 h after dinner / Number of patients on replacement therapy with LT4 tablets)

To evaluate any possible offset between treatment standards for hypothyroidism and the real-life management of patient4 months for each phase

To evaluate, in the real-life management of the hypothyroidism therapy, possible deviations from national and international clinical practice recommendations (CPR) in evidence-based guidelines (EBGs). Four EBGs and 39 CPRs have provided the basis on which 22 treatment management indicators have been identified (e.g. Number of Patients on LT4 replacement therapy who are not taking oral solution or softgel formulations are on absorption-hindering medication and/or do not comply with timing in relation to meals / Number of patients on LT4 replacement therapy who do not comply with the prescribed timing before meals and/or are taking absorption-hindering medication; Number of patients on replacement therapy with TSH in the ATA target range/ Number of patients on replacement therapy with known TSH; Number of patients on replacement therapy, taking LT4 tablets at least 60' before breakfast or at least 3 h after dinner / Number of patients on replacement therapy with LT4 tablets)

Secondary Outcome Measures
NameTimeMethod
Clinical profile evaluation of hypothyroidism4 months for each phase

Assessment of age, gender, weight, hormonal hypothyroidism status (TSH, FT3, FT4), comorbidity, treatment of hypothyroidism and other pharmacological therapies of patients with hypothyroidism

Trial Locations

Locations (20)

ULSS1 Belluno San Martino

๐Ÿ‡ฎ๐Ÿ‡น

Belluno, Italy

Ospedale Versilia

๐Ÿ‡ฎ๐Ÿ‡น

Camaiore, Italy

Ospedale di Canicattรฌ

๐Ÿ‡ฎ๐Ÿ‡น

Canicattรฌ, Italy

Garibaldi Nesima

๐Ÿ‡ฎ๐Ÿ‡น

Catania, Italy

Ospedale Gubbio-Gualdo Tadino

๐Ÿ‡ฎ๐Ÿ‡น

Gubbio, Italy

ASL Latina

๐Ÿ‡ฎ๐Ÿ‡น

Latina, Italy

Ospedale S. Andrea

๐Ÿ‡ฎ๐Ÿ‡น

Massa Marittima, Italy

Ospedale Del Mare

๐Ÿ‡ฎ๐Ÿ‡น

Napoli, Italy

Ospedale S. Croce di Moncalieri - ASL TO5

๐Ÿ‡ฎ๐Ÿ‡น

Moncalieri, Italy

Ospedale Maggiore di Novara

๐Ÿ‡ฎ๐Ÿ‡น

Novara, Italy

Ospedale "Bianchi-Melacrino-Morelli"

๐Ÿ‡ฎ๐Ÿ‡น

Reggio Calabria, Italy

Casa Sollievo della Sofferenza

๐Ÿ‡ฎ๐Ÿ‡น

San Giovanni Rotondo, Italy

Ospedale Civico di Partinico

๐Ÿ‡ฎ๐Ÿ‡น

Palermo, Italy

Ospedale di Castiglione del Lago, Medicina del Trasimeno

๐Ÿ‡ฎ๐Ÿ‡น

Castiglione Del Lago, Italy

Ospedale G.B. Morgagni - P.L. Pierantoni

๐Ÿ‡ฎ๐Ÿ‡น

Forlรฌ, Italy

Ospedale G.P. Delogu

๐Ÿ‡ฎ๐Ÿ‡น

Ghilarza, Italy

Ospedale "F. Veneziale"

๐Ÿ‡ฎ๐Ÿ‡น

Isernia, Italy

Ospedale Fatebenefratelli

๐Ÿ‡ฎ๐Ÿ‡น

Napoli, Italy

AOU di Sassari

๐Ÿ‡ฎ๐Ÿ‡น

Sassari, Italy

Ospedale San Paolo

๐Ÿ‡ฎ๐Ÿ‡น

Savona, Italy

ยฉ Copyright 2025. All Rights Reserved by MedPath